[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349832-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349832-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","in-vitro-experiments-and-bioinformatic-analyses-implicate-kat2a-in-the-occurrence-and-development-of-hepatocellular-carcinoma","In vitro experiments and bioinformatic analyses implicate KAT2A in the occurrence and development of hepatocellular carcinoma","","In vitro experiments and bioinformatic analyses investigate how KAT2A contributes to hepatocellular carcinoma (LIHC). The study quantifies KAT2A expression in LIHC tissues using TCGA, links expression with immune cell infiltration via single-cell analysis, and assesses prognosis with Kaplan–Meier survival and Cox regression. Functional relevance is explored using Gene Ontology and KEGG enrichment, followed by in vitro validation of effects on proliferation and migration. Results show KAT2A is significantly upregulated and promotes LIHC cell proliferation and migration, suggesting prognostic and immunotherapy target potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/in-vitro-experiments-and-bioinformatic-analyses-implicate-kat2a-in-the-occurrence-and-development-of-hepatocellular-carcinoma/349832/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/in-vitro-experiments-and-bioinformatic-analyses-implicate-kat2a-in-the-occurrence-and-development-of-hepatocellular-carcinoma/349832.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does KAT2A play in hepatocellular carcinoma according to the study?","Question",{"text":63,"@type":64},"KAT2A is reported as significantly upregulated in LIHC tissues and associated with promoting LIHC cell proliferation and migration, indicating a key pro-tumor role.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was KAT2A expression and its clinical relevance evaluated?",{"text":68,"@type":64},"KAT2A expression levels were assessed in LIHC tissues using TCGA data, then related to immune cell infiltration using single-cell analysis and to patient prognosis using Kaplan–Meier and Cox regression.",{"name":70,"@type":61,"acceptedAnswer":71},"What methods were used to explore the biological functions of KAT2A?",{"text":72,"@type":64},"The study used Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses to infer potential biological functions.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349832,1790179465,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIn vitro experiments and bioinformatic analyses implicate KAT2A in the occurrence and development of hepatocellular carcinoma  \nZhen-Yue Xu, Jian-Hui Tan, Jia-Xing Li, Shi-Wei Huang, Jun-Er Xu, Guo-Hui Zhong, Jing-Wei Zhai, Xiao-Yu Tan & Guo-Hua Liu􀀍  \nHepatocellular carcinoma (LIHC) is a major global health concern, ranking as the sixth most common cancer and the fourth leading cause of cancer-related mortality worldwide, highlighting the urgent need to develop reliable diagnostic tools, biomarkers, and therapeutic targets to improve early detection and reduce mortality; KAT2A, a histone lysine acetyltransferase, plays crucial roles in multiple biological processes including chromatin remodeling, transcriptional regulation, cell cycle control, and apoptosis initiation, yet its specific role in the initiation and progression of hepatocellular carcinoma remains poorly understood; in this study, we assessed KAT2A expression levels in liver hepatocellular carcinoma tissues using data from theTCGA database and further analyzed its association with immune cell infiltration through single-cell data analysis, followed by evaluating the relationship between KAT2A and patient prognosis using Kaplan–Meier survival analysis combined with Cox regression modeling, while also exploring its potential biological functions via Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses, and finally validating the impact of KAT2A on the proliferation and migration of hepatocellular carcinoma cells through in vitro experiments; our findings revealed that KAT2A is significantly upregulated in LIHC tissues and plays a key role in promoting the proliferation and migration of LIHC cells, suggesting that KAT2A may serve as a novel prognostic biomarker and a promising therapeutic target for immunotherapy in hepatocellular carcinoma.  \nKeywords KAT2A, Hepatocellular carcinoma, Single-cell, Immune infiltration  \nLIHC holds the position of the sixth most common cancer worldwide and is responsible for the fourth highest number of cancer-related deaths globally. Annually, the disease is associated with approximately 841,000 new cases and results in around 782,000 fatalities1. A significant challenge in the management of LIHC arises from the fact that many patients are diagnosed when the cancer is in intermediate to advanced stages. This late diagnosis adversely affects treatment outcomes, as evidenced by a disheartening five-year survival rate of only 18%2. In recent years, immunotherapy has emerged as a pivotal strategy aimed at combatting LIHC. This treatment approach concentrates on the inhibition of immune checkpoints, thereby bolstering the capacity of immune cells to detect and eliminate cancer cells3. One of the dominant immune checkpoints in this context is programmed cell death protein 1 (PD-1), which is primarily present on activated T cells, B cells, and macrophages. PD-1 is known to suppress the activation of specific T cells when it binds to its ligands, PD-L1 and PD-L2 . Notably, PD-L1 is often highly expressed on the surfaces of tumor cells. The interaction between PD-L1 on these tumor cells and PD-1 on immune cells facilitates tumor immune evasion, thereby impairing the ability of the immune system to eliminate cancerous cells4,5. Recent advancements in the field of LIHC treatment have focused on immunotherapies that target the PD-1/PD-L1 axis, as well as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)6,7. However, the application of anti-PD-1 and anti-PD-L1 inhibitors is not without complications; these treatments can lead to several immune-related side effects. Patients may experience increased levels of  \nDepartment of Hepatobiliary Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524023, Guangdong, China. 􀀍 email: [lgheagle@126.com](lgheagle@126.com)  \n[www. nature.com/scientificreports/](www.","cbCaiuC8T5kegIzN","https://ap.wps.com/l/cbCaiuC8T5kegIzN","pdf",2657853,15,"English","# Background\n## Hepatocellular carcinoma burden and diagnosis\n## Immunotherapy and PD-1/PD-L1 axis\n## Need for new biomarkers\n# KAT2A in cancer biology\n# Study design and data sources\n# Statistical analysis and functional exploration\n## Prognostic assessment\n## Enrichment analyses\n# Experimental validation\n## Proliferation and migration","[{\"question\":\"What role does KAT2A play in hepatocellular carcinoma according to the study?\",\"answer\":\"KAT2A is reported as significantly upregulated in LIHC tissues and associated with promoting LIHC cell proliferation and migration, indicating a key pro-tumor role.\"},{\"question\":\"How was KAT2A expression and its clinical relevance evaluated?\",\"answer\":\"KAT2A expression levels were assessed in LIHC tissues using TCGA data, then related to immune cell infiltration using single-cell analysis and to patient prognosis using Kaplan–Meier and Cox regression.\"},{\"question\":\"What methods were used to explore the biological functions of KAT2A?\",\"answer\":\"The study used Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses to infer potential biological functions.\"}]","In vitro experiments and bioinformatic analyses implicate KAT2A in the occurrence and development of hepatocellular carcinoma | PDF",1790085869,38,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c745bee3088cface8c7273d7ee7f2657.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4558f588711bd1c12cc55cfd396c871c.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86bb8417b1377d09f12c3d373f84bffd.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3e14b0628cfb60998df595df6c9ec53.webp",980,1287]